Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP

Sponsor
Ruijin Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02002793
Collaborator
RenJi Hospital (Other)
40
1
2
48
0.8

Study Details

Study Description

Brief Summary

This study aims to standardized the process of mini-invasive abdominal draniage of SAP in early stage.To determine the indications and occasion.

Condition or Disease Intervention/Treatment Phase
  • Other: Early stage abdominal drainage
  • Other: Late stage abdominal drainage
N/A

Detailed Description

Pancreatitis associated ascetic fluids(PAAF) gather with the beginning of SAP and induced IAP(intra-abdominal pressure) increasement.With an excess of 12mmHg ,IAP presents as IAH(intra-abdominal hypertension) and when a ≥20mmHg IAP accompanied with at least one organ's dysfunction it is ACS(abdominal compartment syndrome).Previous recommended theraphy of ACS is laparotomy.However,with inherited advantages such as ease-to-operate and minimal invassiveness, early stage mini-invasive abdominal drainage therapies , for example, percutaneous catheter drainage(PCD) instructed by ultrasound or CT ,have shown a promised future in recent years. It is reported that patients acquired PCD decreased 81% in operation rate compared to those who did not and had lower mortality rate. Whereas, the operation flow of early stage mini-invasive abdominal drainage remains controversial, and whose validity calls for evidence from large-scale clinical trials.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP
Study Start Date :
Aug 1, 2013
Anticipated Primary Completion Date :
Sep 1, 2016
Anticipated Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Early stage abdominal drainage

SAP patients who matches one of the following criteria:1.Intravesical pressure≥20cmH2O or 2.CT images:acute peripancreatic liquid collection should have early stage abdominal drainage immediately;

Other: Early stage abdominal drainage
Ultrasound/CT/GUS guided abdominocentesis and drainage with single-chamber deep venous catheters shoule be implemented and the catheter should be removed when abdominal drainage flow≤100ml in two successive days;

Other: Late stage abdominal drainage

Despite that it matches one of the cirteria as the study group:1.Intravesical pressure≥20cmH2O or 2.CT images:acute peripancreatic liquid collection, the patients continue acquire prearranged integrative treatment and will not accept early stage abdominal drainage until any of the followings emerge:1.Intra-abdominal apartment syndrome; 2. Pancreatic pseudocyst;3. Pancreatic or peripancreatic necrosis;

Other: Late stage abdominal drainage
Despite that it matches one of the cirteria as the study group:1.Intravesical pressure≥20cmH2O or 2.CT scan:acute peripancreatic liquid collection, the patients continue acquire prearranged integrative treatment and will not accept early stage abdominal drainage until any of the followings emerge:1.Intra-abdominal apartment syndrome; 2. Pancreatic pseudocyst;3. Pancreatic or peripancreatic necrosis;

Outcome Measures

Primary Outcome Measures

  1. Rates of ACS in 28 days since outbreaks [28 days]

    Time of first attacks of these situations that have to be surgically interfered in 28 days since onsets: ACS or pancreatic necrosis, abdominal hemorrhage, pancreatic abscess or pancreatic pseudocyst which brings symptoms or complications or increase in size;rates of organs' dysfunction, abdominal infection and reuse of drainage;

Secondary Outcome Measures

  1. Rates of surgical interfere, MODS or death in 6 months since outbreaks [6 months]

    Rates of mortality or organs' dysfunction; rates of complications, including: pancreatic leakage, pancreatic pseudocysts in need of surgical interfere, pancreatic abscess, bile duct stricture and pancreatic insufficiency; times of surgery, hospital stay, time in ICU and hospitalization expense;

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

1.Diagnosis of pancreatitis 2.Onset of abdominal pain within 72h 3.Moderate severe or severe AP according to Atlanta criteria revisited in 2012 4.Intravesical pressure≥20cmH2O 4.CT images:acute peripancreatic liquid collection

-

Exclusion Criteria:

1.Pregnancy 2.Heart function: NYHA >II 3.Pacemaker implantation 4.COPD 5.CKD 6.Pre-existing disease with life expectancy < 3 months 7.CT images:No acute peripancreatic liquid collection 8.Intravesical pressure>25cmH2O 9.At least one organ'S newly emerged dysfunction

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ruijin Shanghai Shanghai China 20000

Sponsors and Collaborators

  • Ruijin Hospital
  • RenJi Hospital

Investigators

  • Study Director: erzhen Chen, Professor, Emergency intensive care unit of Ruijin Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Erzhen Chen, Professor, Ruijin Hospital
ClinicalTrials.gov Identifier:
NCT02002793
Other Study ID Numbers:
  • SAP bundle-abdominal drainage
First Posted:
Dec 6, 2013
Last Update Posted:
Dec 6, 2013
Last Verified:
Dec 1, 2013
Keywords provided by Erzhen Chen, Professor, Ruijin Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 6, 2013